Spanish company files for mastitis probiotic health claim

By Annie Harrison-Dunn contact

- Last updated on GMT

An estimates 10% of breastfeeding women are affected by mastitis, whereby the breast tissue becomes painful and inflamed. © iStock.com / AjFilGud
An estimates 10% of breastfeeding women are affected by mastitis, whereby the breast tissue becomes painful and inflamed. © iStock.com / AjFilGud

Related tags: Milk, Bacteria

The Spanish firm Biosearch Life has filed for a health claim linking a probiotic strain with the reduced risk of painful inflammation of the breast during breastfeeding.

The article 14 claim reads: “Lactobacillus fermentum CECT5716 decreases the Staphylococcus load in breast milk. High Staphylococcus load in breast milk is a risk factor for mammary bacterial dysbiosis/mastitis.”

In January this year Biosearch Life was granted a European patent for the use of “mammalian milk microorganisms, compositions containing them and their use for the treatment of mastitis​”. 

“Currently mastitis is treated with analgesics but this treatment does not solve the infection problem,”​ its scientific director Dr Mónica Olivares said at the time.

“In cases of mastitis showing severe pain, antibiotics are prescribed. However, the microorganisms responsible for mastitis usually generate biofilms and antibiotic resistance which causes failed therapies or recurrences that ultimately lead to the abandonment of breastfeeding.”

One in ten

Mastitis is often caused by a build-up of milk within the breast because of feeding problems.

In some cases this built-up milk can also become infected with bacteria such as Staphylococcus.

According to a review of data by the World Health Organisation​ (WHO) in 2000, the incidence of mastitis and breast abscess occur in all populations regardless of breastfeeding norms, with reported rates varying from few to 33% of lactating women.

mastitis
WHO review of data 

The UK’s National Health Service (NHS) estimates up to one in every ten breastfeeding women are affected by mastitis, usually within the first three months after giving birth.

The condition causes the breast tissue to become painful and inflamed. 

It can also lead to breast abscesses if not treated and it is estimated that one in ten women who develop abscesses are unable to breastfeed using the affected breast again.

Health claim pending

According to the European Food Safety Authority’s (EFSA) register of questions the health claim will be processed within the legal deadline for such dossiers, meaning the Parma-based authority has five months to complete its evaluation once the application is considered complete.

Article 14 claims under the European nutrition and health claims regulation (NHCR)​ refer to children's development or health or to the reduction of disease risk.

EFSA’s dietetic products, nutrition and allergies (NDA) panel has so far received 268 applications, 103 applications of which were withdrawn.

To date 75 article 14 scientific opinions have been adopted.

Related news

Show more

Related products

show more

Skin-Gut Axis: The Potential of Pomella®

Skin-Gut Axis: The Potential of Pomella®

Gee Lawson Nutritional - LEHVOSS Group | 02-Nov-2018 | Technical / White Paper

When skin is exposed to oxidative stress, the effectiveness of the endogenic antioxidant system can be significantly compromised. Pomegranate, a natural...

 Cannabidiol: Should you invest in it?

Cannabidiol: Should you invest in it?

The Whitehouse Consultancy | 17-Oct-2018 | Technical / White Paper

An increasing number of CBD containing products are appearing on the market and consumer interest in this substance is rising.

Related suppliers

Follow us

Featured Events

View more

Products

View more

Webinars